Artigos de revistas sobre o tema "Immune necrotizing myopathies"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Immune necrotizing myopathies".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Mohammed, Abdel Gaffar A., Ayanda Gcelu, Farzana Moosajee, Stella Botha e Asgar Ali Kalla. "Immune Mediated Necrotizing Myopathy: Where do we Stand?" Current Rheumatology Reviews 15, n.º 1 (12 de dezembro de 2018): 23–26. http://dx.doi.org/10.2174/1573397114666180406101850.
Texto completo da fonteAllenbach, Yves, e Olivier Benveniste. "Peculiar clinicopathological features of immune-mediated necrotizing myopathies". Current Opinion in Rheumatology 30, n.º 6 (novembro de 2018): 655–63. http://dx.doi.org/10.1097/bor.0000000000000547.
Texto completo da fonteAkbar, Shalla, Sandhya Dasaraju e Osama Elkadi. "A Case of Immune-Mediated Necrotizing Myopathy With Associated Skeletal Muscle Involvement by Sarcoid Granulomata: A Rare Association". American Journal of Clinical Pathology 152, Supplement_1 (11 de setembro de 2019): S69. http://dx.doi.org/10.1093/ajcp/aqz113.078.
Texto completo da fontePinal-Fernandez, Iago, e Andrew L. Mammen. "Spectrum of immune-mediated necrotizing myopathies and their treatments". Current Opinion in Rheumatology 28, n.º 6 (novembro de 2016): 619–24. http://dx.doi.org/10.1097/bor.0000000000000335.
Texto completo da fonteLee, Jong-Mok. "Immune-Mediated Necrotizing Myopathy: A Review for Clinicians". Journal of Electrodiagnosis and Neuromuscular Diseases 24, n.º 3 (31 de dezembro de 2022): 57–61. http://dx.doi.org/10.18214/jend.2022.00087.
Texto completo da fonteKnauss, Samuel, Corinna Preusse, Yves Allenbach, Sarah Leonard-Louis, Mehdi Touat, Norina Fischer, Helena Radbruch et al. "PD1 pathway in immune-mediated myopathies". Neurology - Neuroimmunology Neuroinflammation 6, n.º 3 (10 de abril de 2019): e558. http://dx.doi.org/10.1212/nxi.0000000000000558.
Texto completo da fonteSwafford, Collin, e E. Steve Roach. "Juvenile Dermatomyositis and the Inflammatory Myopathies". Seminars in Neurology 40, n.º 03 (6 de abril de 2020): 342–48. http://dx.doi.org/10.1055/s-0040-1705120.
Texto completo da fonteMecoli, Christopher A., Arash H. Lahouti, Robert A. Brodsky, Andrew L. Mammen e Lisa Christopher-Stine. "High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies". Neurology - Neuroimmunology Neuroinflammation 4, n.º 5 (11 de julho de 2017): e381. http://dx.doi.org/10.1212/nxi.0000000000000381.
Texto completo da fonteChiapparoli, Ilaria, Claudio Galluzzo, Carlo Salvarani e Nicolò Pipitone. "A glance into the future of myositis therapy". Therapeutic Advances in Musculoskeletal Disease 14 (janeiro de 2022): 1759720X2211002. http://dx.doi.org/10.1177/1759720x221100299.
Texto completo da fontePark, Sunha, Dae-Hyun Jang, Jae-Min Kim e Nara Yoon. "Prominent Asymmetric Muscle Weakness and Atrophy in Seronegative Immune-Mediated Necrotizing Myopathy". Diagnostics 11, n.º 11 (8 de novembro de 2021): 2064. http://dx.doi.org/10.3390/diagnostics11112064.
Texto completo da fonteAllenbach, Yves, Louiza Arouche-Delaperche, Corinna Preusse, Helena Radbruch, Gillian Butler-Browne, Nicolas Champtiaux, Kuberaka Mariampillai et al. "Necrosis in anti-SRP+ and anti-HMGCR+myopathies". Neurology 90, n.º 6 (12 de janeiro de 2018): e507-e517. http://dx.doi.org/10.1212/wnl.0000000000004923.
Texto completo da fonteBondarenko, Inna B., Liubov A. Ponomareva e Elena N. Popova. "Clinical types of lung disease in polymyositis and dermatomyositis". Clinical review for general practice 2, n.º 4 (16 de maio de 2021): 34–39. http://dx.doi.org/10.47407/kr2021.2.4.00058.
Texto completo da fontePetreski, Tadej, Nejc Piko, Timotej Petrijan, Benjamin Dvoršak, Radovan Hojs e Sebastjan Bevc. "Statin-Associated Necrotizing Myopathy Leading to Acute Kidney Injury: A Case Report". Case Reports in Nephrology and Dialysis 11, n.º 2 (17 de junho de 2021): 129–35. http://dx.doi.org/10.1159/000515584.
Texto completo da fonteSilva, André Macedo Serafim, Eliene Dutra Campos e Edmar Zanoteli. "Inflammatory myopathies: an update for neurologists". Arquivos de Neuro-Psiquiatria 80, n.º 5 suppl 1 (maio de 2022): 238–48. http://dx.doi.org/10.1590/0004-282x-anp-2022-s131.
Texto completo da fonteKamperman, Renske G., Anneke J. van der Kooi, Marianne de Visser, Eleonora Aronica e Joost Raaphorst. "Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review". International Journal of Molecular Sciences 23, n.º 8 (13 de abril de 2022): 4301. http://dx.doi.org/10.3390/ijms23084301.
Texto completo da fonteFischer, Norina, Corinna Preuße, Josefine Radke, Debora Pehl, Yves Allenbach, Udo Schneider, Eugen Feist et al. "Sequestosome‐1 (p62) expression reveals chaperone‐assisted selective autophagy in immune‐mediated necrotizing myopathies". Brain Pathology 30, n.º 2 (27 de agosto de 2019): 261–71. http://dx.doi.org/10.1111/bpa.12772.
Texto completo da fonteStenzel, W., H. H. Goebel e E. Aronica. "Review: Immune-mediated necrotizing myopathies - a heterogeneous group of diseases with specific myopathological features". Neuropathology and Applied Neurobiology 38, n.º 7 (14 de novembro de 2012): 632–46. http://dx.doi.org/10.1111/j.1365-2990.2012.01302.x.
Texto completo da fonteTrandafir, Andreea, Violeta Claudia Bonjincă, Delia Tulba e Gelu Onose. "An odd case of immune-mediated necrotizing myopathy, complicated with sagittal, transverse and sigmoid sinus thrombosis". Balneo and PRM Research Journal 14, Vol.14, no. 4 (20 de dezembro de 2023): 630. http://dx.doi.org/10.12680/balneo.2023.630.
Texto completo da fonteBonanno, S., e L. Maggi. "VP.43 Immune-mediated necrotizing myopathies: clinical-serological features of a large Italian cohort of patients". Neuromuscular Disorders 32 (outubro de 2022): S83. http://dx.doi.org/10.1016/j.nmd.2022.07.174.
Texto completo da fonteKolomeychuk, A. A. "Capabilities of magnetic resonance imaging in the diagnosis of idiopathic inflammatory myopathies". Rheumatology Science and Practice 61, n.º 6 (1 de janeiro de 2024): 689–99. http://dx.doi.org/10.47360/1995-4484-2023-689-699.
Texto completo da fonteSan, Pyae Phyo, Nicholas Davies, Venkataramanan Srinivasan, Amrit Samra, Srinivasa Paluri, Simon Ubben, Prateek Kumar, Konstantinos Kiolachidis, Saikat Dhar e Carl-Christian Moor. "175 A case series of anti-HMGCR immune mediated necrotizing myopathy: the West Midlands data". Journal of Neurology, Neurosurgery & Psychiatry 93, n.º 9 (12 de agosto de 2022): e2.134. http://dx.doi.org/10.1136/jnnp-2022-abn2.219.
Texto completo da fonteZerlotin, Roberta, Marco Fornaro, Mariella Errede, Patrizia Pignataro, Clelia Suriano, Maddalena Ruggieri, Silvia Colucci, Florenzo Iannone, Maria Grano e Graziana Colaianni. "Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance". International Journal of Molecular Sciences 24, n.º 3 (27 de janeiro de 2023): 2469. http://dx.doi.org/10.3390/ijms24032469.
Texto completo da fonteLee, Seung-Ah, Hyun Joon Lee, Bum Chun Suh, Ha Young Shin, Seung Woo Kim, Byeol-A. Yoon, Young-Chul Choi e Hyung Jun Park. "Clinical significance of anti-NT5c1A autoantibody in Korean patients with inflammatory myopathies". PLOS ONE 18, n.º 4 (14 de abril de 2023): e0284409. http://dx.doi.org/10.1371/journal.pone.0284409.
Texto completo da fonteMatsuda, Nozomu, Shunsuke Kobayashi, Osamu Hasegawa, Kenji Yoshida, Hitoshi Kubo, Yoshikazu Ugawa e Kazuaki Kanai. "Subclinical involvement of the trunk muscles in idiopathic inflammatory myopathies". Acta Radiologica Open 11, n.º 2 (fevereiro de 2022): 205846012210757. http://dx.doi.org/10.1177/20584601221075796.
Texto completo da fonteKurashige, Takashi, Tomomi Murao, Naoko Mine, Tomohito Sugiura, Yukiko Inazuka, Kazuya Kuraoka, Tetsuya Takahashi, Hirofumi Maruyama e Tsuyoshi Torii. "Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations". Journal of Neuropathology & Experimental Neurology 79, n.º 4 (25 de fevereiro de 2020): 448–57. http://dx.doi.org/10.1093/jnen/nlaa006.
Texto completo da fonteKhelkovskaia-Sergeeva, A., O. Desinova, M. Starovoytova, L. P. Ananyeva, M. Cherkasova e R. Shayakhmetova. "AB0444 СLINICAL-IMMUNOLOGICAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY MYOPATHIES". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de maio de 2021): 1249.3–1250. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3101.
Texto completo da fontede Souza, Jean Marcos, Leonardo Santos Hoff e Samuel Katsuyuki Shinjo. "Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies". Rheumatology International 39, n.º 7 (18 de fevereiro de 2019): 1201–12. http://dx.doi.org/10.1007/s00296-019-04254-3.
Texto completo da fontede Oliveira, Diego Sales, Isabela Bruna Pires Borges, Suely Kazue Nagahashi Marie, Antonio Marcondes Lerario, Sueli Mieko Oba-Shinjo e Samuel Katsuyuki Shinjo. "Exercise training attenuates skeletal muscle fat infiltration and improves insulin pathway of patients with immune-mediated necrotizing myopathies and dermatomyositis". Archives of Rheumatology 38, n.º 2 (21 de outubro de 2022): 189–99. http://dx.doi.org/10.46497/archrheumatol.2023.9257.
Texto completo da fonteDanielsson, Olof, Björn Lindvall, Istvan Gati e Jan Ernerudh. "Classification and Diagnostic Investigation in Inflammatory Myopathies: A Study of 99 Patients". Journal of Rheumatology 40, n.º 7 (1 de maio de 2013): 1173–82. http://dx.doi.org/10.3899/jrheum.120804.
Texto completo da fonteXiong, Anji, Guancui Yang, Zhuoyao Song, Chen Xiong, Deng Liu, Yu Shuai, Linqian He, Liangwen Zhang, Zepeng Guo e Shiquan Shuai. "Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series". Therapeutic Advances in Neurological Disorders 14 (janeiro de 2021): 175628642199891. http://dx.doi.org/10.1177/1756286421998918.
Texto completo da fonteRobert, M., L. Lessard, T. Fenouil, A. Hot, T. Laumonier, A. Bouche, B. Chazaud, N. Streichenberger e L. Gallay. "POS0490 USEFULNESS OF MHC-II IMMUNO-STAINING ON MUSCLE BIOPSIES IN IDIOPATHIC INFLAMMATORY MYOPATHIES". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de maio de 2022): 499.2–500. http://dx.doi.org/10.1136/annrheumdis-2022-eular.5186.
Texto completo da fonteAllenbach, Y., A. Rigolet, L. Drouot, J. L. Charuel, F. Jouen, F. Jouen, T. Maisonobe et al. "P.14.11 Auto-immune necrotizing myopathies with anti-HMGCR antibodies are related to statin-exposure only for a minority of cases". Neuromuscular Disorders 23, n.º 9-10 (outubro de 2013): 816–17. http://dx.doi.org/10.1016/j.nmd.2013.06.619.
Texto completo da fonteMeyer, A., L. Messer, J. Goetz, B. Lannes, J.-C. Weber, B. Geny, JE Gottenberg e J. Sibilia. "Immune-mediated necrotizing myopathies are serologically heterogeneous and autoantibodies may predict their clinical phenotype: two cases associated with anti-Pl7 antibodies". Scandinavian Journal of Rheumatology 43, n.º 1 (janeiro de 2014): 81–83. http://dx.doi.org/10.3109/03009742.2013.864421.
Texto completo da fontePepper, Elizabeth, Lilian Vilar e Ian M. Ward. "Clinical Characteristics and Prognostic Value of Ro52/SSA Antibodies in Idiopathic Inflammatory Myopathies". JCR: Journal of Clinical Rheumatology 29, n.º 7 (outubro de 2023): 347–53. http://dx.doi.org/10.1097/rhu.0000000000002015.
Texto completo da fonteRobert, M., L. Gallay, P. Petiot, T. Fenouil, L. Lessard, L. Perard, J. Svahn et al. "POS0862 INAUGURAL DROPPED HEAD SYNDROME AND CAMPTOCORMIA IN INFLAMMATORY MYOPATHIES". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de maio de 2022): 725.1–725. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1605.
Texto completo da fonteLopez, B., C. Fuego-Varela, J. Galloway e P. Gordon. "THU0335 IS CARDIOVASCULAR RISK IN INFLAMMATORY MYOPATHIES UNDERESTIMATED?" Annals of the Rheumatic Diseases 79, Suppl 1 (junho de 2020): 398.2–399. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4926.
Texto completo da fonteCorrales-Selaya, C., D. Martínez-López, D. Prieto-Peña, J. L. Martín-Varillas e R. Blanco. "AB0874 EPIDEMIOLOGY AND CLINICAL FEATURES OF IDIOPATHIC INFLAMMATORY MYOPATHIES IN SINGLE REGION IN NORTHERN SPAIN". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de maio de 2023): 1651–52. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2852.
Texto completo da fonteMusset, Lucile, Yves Allenbach, Olivier Benveniste, Olivier Boyer, Xavier Bossuyt, Chelsea Bentow, Joe Phillips et al. "Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study". Autoimmunity Reviews 15, n.º 10 (outubro de 2016): 983–93. http://dx.doi.org/10.1016/j.autrev.2016.07.023.
Texto completo da fonteLarco Rojas, X. E., S. Sáez-Álvarez, P. Pérez-García, C. Sieiro Santos, I. González Fernández, C. Moriano, A. López Robles, M. Martín Martín, C. Álvarez Castro e E. Diez Alvarez. "AB0706 Demographic, clinical and serological characteristics in Idiopathic Inflammatory Myopathies. The role of specific antibodies". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de maio de 2022): 1479.3–1480. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3657.
Texto completo da fonteSuzuki, K., Y. Kondo, S. Ishigaki, S. Takanashi e Y. Kaneko. "AB1630 RISK FACTORS FOR CARDIAC INVOLVEMENT IN IDIOPATHIC INFLAMMATORY MYOPATHIES". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de maio de 2023): 2049.1–2049. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1969.
Texto completo da fonteTurner, Richard Myles, e Munir Pirmohamed. "Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components". Journal of Clinical Medicine 9, n.º 1 (20 de dezembro de 2019): 22. http://dx.doi.org/10.3390/jcm9010022.
Texto completo da fonteDourado, E., A. T. Melo, P. Martins, M. J. Sousa Bandeira, V. Fraga, J. L. Ferraro, A. Saraiva et al. "POS0891 REUMA.pt/MYOSITIS – THE PORTUGUESE REGISTRY OF INFLAMMATORY MYOPATHIES". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de maio de 2022): 742. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3259.
Texto completo da fonteUruha, Akinori, Atsuko Nishikawa, Rie S. Tsuburaya, Kohei Hamanaka, Masataka Kuwana, Yurika Watanabe, Shigeaki Suzuki, Norihiro Suzuki e Ichizo Nishino. "Sarcoplasmic MxA expression". Neurology 88, n.º 5 (30 de dezembro de 2016): 493–500. http://dx.doi.org/10.1212/wnl.0000000000003568.
Texto completo da fonteGalindo-Feria, A. S., B. Horuluoglu, J. Day, C. Cerqueira, S. Proudman, I. E. Lundberg e V. Limaye. "POS0883 DETECTION OF AUTOANTIBODIES AGAINST MUSCLE-SPECIFIC FOUR-AND-A-HALF-LIM DOMAIN 1 (FHL1) IN INFLAMMATORY MYOPATHIES: RESULTS FROM A SINGLE-CENTER COHORT". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de maio de 2021): 697.3–698. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3640.
Texto completo da fonteLi, Wenli, Chuiwen Deng, Hanbo Yang, Xiaolan Tian, Lida Chen, Qingyan Liu, Chang Gao, Xin Lu, Guochun Wang e Qinglin Peng. "Upregulation of the CD155-CD226 Axis Is Associated With Muscle Inflammation and Disease Severity in Idiopathic Inflammatory Myopathies". Neurology - Neuroimmunology Neuroinflammation 10, n.º 5 (25 de julho de 2023): e200143. http://dx.doi.org/10.1212/nxi.0000000000200143.
Texto completo da fonteZhao, Bing, Tingjun Dai, Dandan Zhao, Xiaotian Ma, Cuiping Zhao, Ling Li, Yuan Sun et al. "Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy". Neurology - Neuroimmunology Neuroinflammation 9, n.º 4 (17 de maio de 2022): e1184. http://dx.doi.org/10.1212/nxi.0000000000001184.
Texto completo da fonteRosa, C., K. Chaudhuri, T. Blake, T. Potter e S. Banerjee. "AB0888 CLINICAL CHARACTERISTICS OF ANTI HMGCOA REDUCTASE ANTIBODY POSITIVE IMMUNE MEDIATED NECROTIZING MYOPATHY: CASE SERIES OF 5 PATIENTS FROM A TERTIARY CENTRE". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de maio de 2023): 1659.1–1659. http://dx.doi.org/10.1136/annrheumdis-2023-eular.5438.
Texto completo da fonteAdsuara de Sousa, L. F., R. G. Misse, L. De Macedo Dos Santos, A. Fontes Baptista, C. Tanaka, J. M. D’andréa Greve e S. Katsuyuki Shinjo. "POS0887 TRANSCRANIAL ELECTRICAL STIMULATION IS SAFE AND EFFICIENT IN PATIENTS WITH SYSTEMIC AUTOIMMUNE MYOPATHIES". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de maio de 2021): 699.2–700. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3723.
Texto completo da fonteGraf, M., A. S. L. Von Stuckrad, A. Uruha, J. Klotsche, L. Zorn-Pauly, N. Unterwalder, T. Buttgereit et al. "POS0183 SIGLEC1 AS A TYPE I INTERFERON BIOMARKER IN IDIOPATHIC INFLAMMATORY MYOPATHIES". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de maio de 2021): 305.1–305. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2816.
Texto completo da fonteDe Lorenzo, R., S. Cavalli, F. Bonomi, S. Tronci, S. L. Calvisi, S. Previtali e P. Rovere-Querini. "AB0567 CHARACTERIZATION OF PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHY AND MYOCARDIAL INVOLVEMENT: A MONO-CENTRIC EXPERIENCE." Annals of the Rheumatic Diseases 79, Suppl 1 (junho de 2020): 1580.3–1580. http://dx.doi.org/10.1136/annrheumdis-2020-eular.6248.
Texto completo da fonte